openPR Logo
Press release

Neurovascular Devices Market determined to grow $3,409 Million by 2023 : Revascularization devices segment is projected to grow at fastest CAGR during forecast period

02-15-2019 06:59 PM CET | Health & Medicine

Press release from: Allied Market Research

Neurovascular Devices Market

Neurovascular Devices Market

Neurovascular devices (such as coils) aid in treatment of various neurovascular disorders such as cerebral aneurysms and intracranial atherosclerotic disease. Rise in geriatric population and upsurge in number of patients suffering from neurovascular disorders are expected to drive the market growth. Moreover, increase in adoption of new minimally invasive techniques such as flow diversion and carotid artery stenting boosts the market growth. However, high cost of the devices and dearth of neurosurgeons are expected to impede the market growth.

New report published by Allied Market Research, titled, "Neurovascular Devices Market by Product, and Disease Pathology: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global neurovascular devices market was valued at $2,371 million in 2016, and is projected to reach $3,409 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. The embolization devices segment held more than two-fifths share of the total market in 2016.

Request Sample/ TOC Report @ https://www.alliedmarketresearch.com/request-sample/2278

Embolization devices segment is expected to dominate the market throughout the analysis period, owing to increase in the incidence of neurovascular disorders, such as arteriovenous malformations (AVMs), carotid artery disease, and intracranial atherosclerotic disease. On the other hand, revascularization devices segment is expected to grow at the highest CAGR of 8.5% during the forecast period.

Key Findings of the Neurovascular Devices Market:

• Revascularization devices segment is projected to grow at a CAGR of 8.5% during the forecast period.
• Aneurysm contributed for nearly three-fifths share of the global neurovascular devices market in 2016.
• Ischemic stroke segment is expected to register the highest CAGR of 5.7% during the analysis period.
• France and Germany jointly contributed for more than one-third share of the European neurovascular devices market in 2016.
• Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific neurovascular devices market in 2016.

Asia-Pacific is projected to grow at the highest CAGR of 5.9% during the forecast period owing to improvement in healthcare infrastructures and rise in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs. Technological advancements to develop cost-effective devices in these nations offer a lucrative opportunity for the market growth.

The major companies profiled in the report include Stryker Corporation, Medtronic Plc., Johnson & Johnson, Terumo Corporation, Penumbra, Inc., Integer Holdings Corporation, Microport Scientific Corporation, Merit Medical Systems, Inc., W.L. Gore & Associates, and Acandis GmbH & Co. KG.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/2278

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurovascular Devices Market determined to grow $3,409 Million by 2023 : Revascularization devices segment is projected to grow at fastest CAGR during forecast period here

News-ID: 1593152 • Views:

More Releases from Allied Market Research

Bridging Healthcare Gaps: LAMEA Medical Software Market Surges Amidst Technological Advancements | CAGR of 13.4%
Bridging Healthcare Gaps: LAMEA Medical Software Market Surges Amidst Technologi …
In the dynamic landscape of healthcare, technological innovations play a pivotal role in enhancing patient care, streamlining operations, and driving efficiency. Within the Latin America, Middle East, and Africa (LAMEA) region, the medical software market is experiencing a remarkable surge, propelled by the convergence of cutting-edge technologies and evolving healthcare needs. This surge underscores the region's commitment to leveraging digital solutions to address healthcare challenges and foster inclusive healthcare access.
Revolutionizing Healthcare: Protein Engineering Market Soars with a CAGR of 13.2%
Revolutionizing Healthcare: Protein Engineering Market Soars with a CAGR of 13.2 …
The global protein engineering market witnessed a remarkable rise, surging from $2.2 billion in 2022 to a projected $7.7 billion by 2032, with a robust Compound Annual Growth Rate (CAGR) of 13.2% between 2023 and 2032. This surge is attributed to the expanding applications across biopharmaceuticals, industrial sectors, and research domains. Notably, the escalation in cancer cases plays a pivotal role in propelling market growth, as protein engineering spearheads the
Tomato Puree Market Value Projected to Expand | $7.7 Billion by 2032 With CAGR of 4.1%
Tomato Puree Market Value Projected to Expand | $7.7 Billion by 2032 With CAGR o …
The tomato puree market was valued at $5.2 billion in 2022, and is estimated to reach $7.7 billion by 2032, growing at a CAGR of 4.1% from 2023 to 2032. Tomato puree is a thick liquid or paste made by cooking and straining tomatoes to remove seeds and skins. It is a concentrated form of tomatoes that retains the rich flavor and vibrant color of the tomatoes. In the process
Olive Oil Market to Witness Robust Expansion | $30.2 Billion by 2032
Olive Oil Market to Witness Robust Expansion | $30.2 Billion by 2032
The olive oil market size was valued at $18.6 billion in 2022, and is estimated to reach $30.2 billion by 2032, growing at a CAGR of 5.2% from 2023 to 2032. The Olive Oil Industry is driven by a rise in the number of cooking shows and food blogging. Celebrity chefs and influencers often showcase olive oil as a star ingredient in various culinary creations, emphasizing its versatility and health benefits.

All 5 Releases


More Releases for Neurovascular

Neurovascular Devices Market Size - Forecast to 2026
As per the research conducted by GME, the Neurovascular Devices Market is estimated to be valued at USD 2.87 billion in 2021 and is projected to reach USD 4.37 billion by 2026 at a CAGR of 8.75%. The global neurovascular devices market is being driven by the escalating incidence of neurovascular diseases amongst patients around the world as well as the growing elderly demographic. Browse 151 Market Data Tables and 111
Brain Aneurysm Treatment - Modern Neurovascular Techniques
Brain aneurysm is a development of bulge in brain vessels. This bulging puts pressure on the nerves or brain tissues. This bulge may rupture or burse and can cause brain hemorrhage, which can cause death of the patient. Get PDF Brochure of Research Study @ https://bit.ly/2zir2hL Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm. The global brain aneurysm treatment market
Neurovascular Devices Market: Opportunities and Challenges
The Neurovascular Devices Market is expected to reach USD 2.62 billion by 2021 from USD 1.74 billion in 2016, at a CAGR of 8.6% from 2016 to 2021. Increasing research activities in the field of neurovascular therapies Neurovascular devices are witnessing a growing demand among the major stakeholders globally, due to increasing clinical research activities in the field of neurovascular therapies, which offer credible clinical data related to their safety & efficacy
Global Neurovascular Devices Market: Rising Geriatric Population and Neurovascul …
Besides exponential rise in occurrences of critical neurovascular ailments such as ischemic stroke and aneurysm amongst others, burgeoning advances in product enhancements, improved reimbursements, and surged healthcare expenditure are accounted to etch growth in global neurovascular devices market in forthcoming years. These market highlights are in line with Market Research Hub's (MRH) recent research report titled, 'Global Neurovascular Devices Market Analysis, Size, Share, Segmentation and Competitive Landscape (2013 - 2017) and
Future For Neurovascular Devices Market...By 2024
MaketStudyReport.com adds a New Neurovascular Devices Market Research Report for the period of 2018 - 2024 that shows the growth of the market for next few years along with providing a competitive landscape. Neurovascular Devices Market will reach USD 2.0 billion by 2024; as per a new research report. Increasing incidences and financial cost burden associated with neurological disorders such as acute ischemic stroke and brain aneurysm will drive neurovascular devices industry
Neurovascular Devices Market - Regional Outlook 2017 - 2025
Global Neurovascular Devices Market: Snapshot Over the past decade, neurointerventional techniques have gained increased significance in the management of acute ischemic strokes. Endovascular and microsurgical devices are fast gaining traction as minimally invasive techniques for the management of brain aneurysms. In recent years, advances in balloon- and stent- assisted coiling in endovascular therapies have expanded the options for surgeons and patients in the treatment of aneurysms. The rising morbidity and mortality